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Background: Recombinant proteins fused with specific cleavage sequences are widely used as substrate for
quantitatively analyzing the activity of proteases. Here we propose a new fusion platform for multiple proteases, by
using diaminopropionate ammonia-lyase (DAL) as the fusion protein. It was based on the finding that a fused
His6-tag could significantly decreases the activities of DAL from E. coli (eDAL) and Salmonella typhimurium (sDAL).
Previously, we have shown that His6GST-tagged eDAL could be used to determine the activity of tobacco etch virus
protease (TEVp) under different temperatures or in the denaturant at different concentrations. In this report, we will
assay different tags and cleavage sequences on DAL for expressing yield in E. coli, stability of the fused proteins and
performance of substrate of other common proteases.
Results: We tested seven different protease cleavage sequences (rhinovirus 3C, TEV protease, factor Xa, Ssp DnaB
intein, Sce VMA1 intein, thrombin and enterokinase), three different tags (His6, GST, CBD and MBP) and two different
DALs (eDAL and sDAL), for their performance as substrate to the seven corresponding proteases. Among them, we
found four active DAL-fusion substrates suitable for TEVp, factor Xa, thrombin and DnaB intein. Enterokinase cleaved
eDAL at undesired positions and did not process sDAL. Substitution of GST with MBP increase the expression level of the
fused eDAL and this fusion protein was suitable as a substrate for analyzing activity of rhinovirus 3C. We demonstrated
that SUMO protease Ulp1 with a N-terminal His6-tag or MBP tag displayed different activity using the designed
His6SUMO-eDAL as substrate. Finally, owing to the high level of the DAL-fusion protein in E. coli, these protein substrates
can also be detected directly from the crude extract.
Conclusion: The results show that our designed DAL-fusion proteins can be used to quantify the activities of both
sequence- and conformational-specific proteases, with sufficient substrate specificity.
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Proteases play key roles in many fundamental cellular,
viral processes and widely used as tools in biotechnology
[1,2]. One major usage of proteases is to cleave off fu-
sion tags from target proteins, which are either used as
solubility tag and for affinity tag. The solubility tags, for
example, small ubiquitin-related modifier (SUMO) tag,
have a promoting effect on the expression and folding of
the target protein. The affinity tags such as hexa-histidine
tag (His6-tag) and chitin binding domain (CBD) facili-
tate rapid purification of the fusion protein. Others tags* Correspondence: fanjun@ahau.edu.cn
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unless otherwise stated.including maltose-binding protein (MBP) and glutathi-
one S-transferase (GST) have both solubility and affinity
benefits [3]. After purification, these fused tags are usu-
ally required to be removed, which otherwise would
often inhibit the target protein activity, affect protein
crystallization and cause the undesirable immune re-
sponse for proteins in human therapy [3-6].
Several specific proteases have been used for this
propose. Among them, TEVp protease (TEVp), rhinovirus
3C protease (R3P), thrombin, factor Xa, enterokinase is
sequence-specific [4]. SUMO protease Ulp1 is dependent
on the conformation of SUMO [5]. Some inteins and
protease are processed by inducible self-cleavage [6].
To remove the fused tag, a linker sequence between the
tag and target protein is used as the site for specifictd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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of fusion protein can also be used as substrate to measure
the activity of protease for developing more potent and
specific proteases, such as HIV protease and caspase-3 [7].
In the past, different types of protease substrates had
been developed. One is using small molecule fluorescence
probes. These probes are highly sensitive and can be used
to monitor the cleavage kinetics of the target protease [8].
Another approach is to use the fluorescence resonance en-
ergy transfer construct between two fluorescent protein
conjugates. This method has been wildly applied in the de-
velopment of highly sensitive and specific protease activity
assays in vivo and in vitro [9-11]. However, these synthetic
probes are generally expensive. On the other hand, fusion
protein substrates produced in E. coli are more cost-
effective, and several of them had been tested for analyzing
the sequence-specific proteases in vitro [12-14], or in vivo
[15,16], or both [7]. Another fusion protein substrate has
also been developed for in vitro analyzing SUMO-specific
protease [17]. However, assays of these designed fusion
protein substrates are inconvenient, because separation of
the cleaved and uncleaved products is required to quantify
the cleavage [12,13,18-20]. In addition, the ability of
several protein substrates is further limited by their low
stability under relatively high temperature or in the
presence of denaturant [7,12-14]. Thus, developing new
fusion protein substrate that has better stability and can
be directly assayed is of great interest.
Diaminopropionate ammonia-lyase (DAL, EC 4.3.1.15),
is a member of the fold type II family of pyridoxal 5’ phos-
phate (PLP) dependent enzymes. DAL catalyzes α, β-
elimination reaction of L- or D-α, β- Diaminopropionate
(L-DAP and D-DAP) to form pyruvate and ammonia [21].
It was shown that a N-terminal His6-tag significantly
could decrease the E. coli DAL (eDAL) or S. typhimurium
DAL (sDAL) activity [21]. Based on this finding, our previ-
ous study demonstrated that the activity of His6GST fused
eDAL (GST-eDAL) was also decreased and could be
rescued dramatically (~10-fold) after TEV cleavage of
the His6GST-tag. Since the cleaved product (eDAL) can
be directly assayed without further separation, His6GST-
eDAL allows quantitative analysis of TEV protease (TEVp)
variants activity in vitro and within E. coli cells [22]. Other
tests also indicated that this fusion protein substrate
can be used for detecting TEVp stability at temperature
30-45°C or in the supplementary denaturant including
urea or guanidine hydrochloride up to 2 M [23]. Here,
we broadened the application of the fused DAL (DAL-
fusion) as substrate for other specific proteases. First, by
combining different fused tags and the protease cleav-
age sequences, we selected the top DAL-fusion con-
structs with soluble expression of the fusion protein in
E. coli. Then, we determined performance of the select
DAL-fusion proteins as substrate for the correspondingproteases. From this systematic analysis, we developed
four active DAL-fusion substrates suitable for TEVp,
factor Xa, thrombin and DnaB intein, and summarized
potential factors that may affect the development of
other fusion protein substrates in the future.Results
Design and overall results of the DAL-fusion substrate
screen
To determine if DAL-fusion can be used as substrate
for other proteases and to select the optimal fusion con-
struct, we designed a library of DAL-fusion constructs,
by combining seven different protease cleavage sequences
(R3P, TEVp, factor Xa, Ssp DnaB intein, Sce VMA1 intein,
thrombin and enterokinase), four different tags (His6,
GST, CBD, MBP) and two different DALs (eDAL and
sDAL), total of seventeen constructs. Among them, we
successfully developed four active DAL-fusion substrates
suitable for TEVp, factor Xa, thrombin and DnaB intein.
In addition, our results also showed that substrate per-
formance varied greatly with various factors. For example,
incorporation of Sce VMA1 intein between CBD and
eDAL caused the low expression level (see Additional
file 1: Figure S1) and we did not further analyze the
VMA1 intein activity. Similarly, no soluble expression
level was obviously detected for CBD fused eDAL contain-
ing Ssp DnaB intein (data not shown), and replacement of
CBD with MBP significantly enhanced production of
the fusion protein. Also, substitution of GST with MBP
increased the soluble yields of the R3P sequence fused
eDAL. Although enterokinase cleaved eDAL at undesired
positions, it did not process sDAL. We also demonstrated
that SUMO protease Ulp1 with an N-terminal His6-tag or
MBP tag displayed different activity using the designed
His6SUMO-eDAL as a substrate. Highlights of the results
are detailed as below.Effects of fused tag on the production and activity of
eDAL or sDAL
To first investigate the initial solubility of the DAL-
fusion protein, we created a T7 promoter expression
vectors for the production of the fusion proteins con-
taining sequences encoding His6MBP, or His6GST or
His6 tags followed by a TevS (TEVp cleavage sequence)
and multiple cloning sites, respectively. Sequences en-
coding eDAL or sDAL were then cloned into the MCS
to create an in-frame fusion of DAL with each tag. All
the constructed proteins were expressed at high level in
E. coli, as detected by Western blot analysis using anti-
His6 antibody (Figure 1A). His6MBP tag was the most
efficient on improving the protein solubility of DAL.
The DAL-fusion proteins were purified by Ni-NTA af-
finity chromatography and displayed relatively high
Figure 1 Overexpression, purification and DAL activity assay of the fusion protein. A. Expression of the soluble fusion protein for eDAL or
sDAL with a specified tag followed by tevS in E. coli. The fusion proteins from the supernatants were detected by Western blot using anti-His6
antibody. The lane 1–6 represented His6MBP-tevS-eDAL, His6MBP-tevS-sDAL, His6GST-tevS-eDAL, His6GST-tevS-sDAL, His6-tevS-eDAL and
His6-tevS-sDAL. B. Purification of the fusion proteins. The fusion proteins were purified by Ni-NTA and analyzed by SDS-PAGE. All the proteins are
indicated by arrows. C. The activity of the DAL as the fusion partner in the crude extracts. D. The activity of the purified fusion proteins for DAL.
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that the fusion proteins were stable in the solution.
We then measured activity of the DAL-fusion proteins
from the crude extract and the purified form (Figure 1C and
1D). These three sDAL-fusion proteins showed different
activities in the crude extract. Similar difference was also
found in the purified forms. This was phenotypically consist-
ent with the expression level of sDAL in E. coli (Figure 1A).
Interestingly, difference in activities of eDAL-fusions from
crude extract was distinct from that of their purified forms,
probably due to the various expression levels.
Effects of protease cleavage sequence on production and
activity of the fused eDAL
To determine the effect of protease cleavage sequence
on the DAL-fusion protein, 5 different protease recogni-
tion sequences, including enterokinase sequence DDDDK
(ekS), factor Xa sequence IEGR (fxS), R3P sequence
LEVLFQG (rpS) etc., were used to link His6-GST tag and
eDAL. For thrombin, two sequences containing either gly-
cine (Gly) or serine (Ser) at the P1’ position of the throm-
bin recognition sequence (LVPRG/S, termed tbS or tbS’)
were also used. Expression of designed DAL-fusion pro-
teins was determined by SDS-PAGE (Figure 2A). All the
fused eDAL proteins were purified and analyzed by SDS-
PAGE analysis (Figure 2B). All fusion proteins had high ex-
pression in E. coli, except the His6GST-rpS-eDAL. Activity
test using the crude extract showed that these fusion pro-
teins again had different DAL activity (Figure 2C), whichare consistent with the difference observed for their puri-
fied forms (Figure 2D). Incorporation of R3P cleavage se-
quence (rpS) severely decreased protein expression level
and DAL activity.
Resistance of DAL Activity to protease activator and
inhibitor
Proteases are classified according to the presence of
catalytic residues including Ser, Cys, Thr, or Glu. The
proteases wildly used for tag removal belong to serine
and cystein proteases. Phenylmethanesulfonyl fluoride
(PMSF) and benzamidine hydrochloride (BzCl) are spe-
cific inhibitor of serine protease. N-ethylmaleimide (NEM)
is an inhibitor specific for cysteine protease. On the
contrary, Ca2+ can activate several proteases including
factor Xa and thrombin [3]. Since different proteases
demand different buffer compositions for sustainable
solubility, stability, and biological activity, it is extremely
important to pre-determine whether DAL activity is resist-
ant to different conditions, particularly to these protease
activators and inhibitors. Therefore, we measured the
DAL activity using the characterized eDAL-fusion pro-
teins in the presence of calcium ion, EDTA, and specific
protease inhibitors including NEM, PMSF and BzCl. All
reagents at tested concentrations slightly activated
eDAL, but the differences were within 10% (Table 1).
Thus, the results suggest that using eDAL-fusion to
measure the protease activity under various conditions
is practicable.
Figure 2 Overexpression, purification and activity assay of eDAL with a His6GST followed by the specified protease cleavage site. A.
SDS-PAGE analysis of the soluble fusion proteins expressed in E. coli. U: uninduced; I: induced. B. SDS-PAGE analysis of the purified fusion proteins.
In the Figure 2A and 2B, all the proteins are indicated by arrows. C. DAL activity of the fusion protein in the crude extracts. D. DAL activity of the
purified fusion protein.
Zhou et al. Microbial Cell Factories 2014, 13:44 Page 4 of 10
http://www.microbialcellfactories.com/content/13/1/44Application of eDAL-fusion coupled activity assay for
sequence-specific proteases
We further determined whether eDAL-fusion proteins
can be used to monitor the protease activity through
their enhanced DAL activity after cleavage. First, we op-
timized the His6GST-rpS-eDAL that was found to be
poorly expressed in E. coli in our previous test. We
substituted His6GST with His6MBP in the fusion protein.
SDS-PAGE analysis showed it with enhanced expression
level in the cells (Figure 3A). This His6MBP-rpS-eDAL
fusion protein from the crude extract was also cleaved effi-
ciently by R3P incubated for different times. In addition,
adding the thiol alkylating agent NEM that inhibits cyst-
eine proteases (such as R3P and TEVp) abolished the
function of R3P and the cleavage of the eDAL-fusion pro-
tein (Figure 3B), supporting the specificity of optimized
His6MPB-rpS-eDAL fusion substrate.
Enzyme assay monitoring the activity of DAL also sup-
port the efficient proteolysis of His6-tevS-eDAL and His6-
tevS-sDAL by a TEVp variant. DAL activities increased
with reaction time, and His6-tevS-sDAL had more sensi-
tivity than His6-tevS-eDAL. Again, in the presence ofTable 1 The effect of some reagents on DAL activity
Reagent Relative activity %
CK 100.00
5 mM EDTA 107.79
2.5 mM Ca2+ 104.43
1 mM NEM 101.67
1 mM BzCI 109.20
1 mM PMSF 109.74NEM, the TEVp activity was inhibited and no increase of
DAL activity was observed when incubated with TEVp
(Figure 3C).
Factor Xa cleaved the corresponding His6GST-fxS-
eDAL at a relatively high speed under standard condition.
Factor Xa is a serine protease that can be inactivated by
PMSF and BzCl. In addition, calcium ions bind to the en-
zyme and function as cofactor for proteolysis [3]. Again
DAL activities were much decreased in the presence of
PMSF, BzCl or EDTA (Figure 3D).
Cleavage specificity of DAL-fusion proteins as thrombin
and enterokinase substrates
To further determine if the DAL-fusion proteins can
also be used to test the specificity of proteases, two
thrombin cleavage sequences (tbS and tbS’) were used
as linker between His6-GST and eDAL. Proteolysis-
DAL activity coupled assay showed that thrombin had
about 1.3 fold more processing efficiency for LVPRS
than LVPRG (Figure 4A), with strong preference of S
at the P’1 position, as previously shown using synthetic
fluorescence peptide probes [24]. Further, adding PMSF
abolished the increase of DAL activity presumably by
inhibiting thrombin for both DAL-fusion substrates
(Figure 4A). This result supports the idea that our de-
signed DAL-fusion protein can display similar sub-
strate specificity as classical synthetic substrate probe
for protease [24].
Another interesting result was seen for His6GST-ekS-
eDAL fusion as substrate of enterokinase. Unexpectedly,
after cleavage of the fusion protein, the activity of the re-
leased eDAL was very low (data not shown). SDS-PAGE
Figure 3 Coupled assay of time course cleavage of the designed fusion protein by proteases. A. SDS-PAGE analysis of expressed His6MBP-
rpS-eDAL in E. coli cells. U: uninduced; I: induced. The protein is indicated by the arrow. B. Time course cleavage activity of His6MBP-rpS-eDAL
from crude extracts using GST fused R3P by coupled assay in the absence or presence of the inhibitor. C. Coupled assay of time course cleavage
of two fusion proteins for eDAL and sDAL from crude extracts by the TEVp variant. D. Coupled assay of time course cleavage of the fusion protein
from crude extracts by factor Xa. The activity of DAL partner was used as a control and subtracted.
Figure 4 Substrate preference and specificity of thrombin and enterokinase by the coupled assay. A. coupled assay of fusion protein
containing tbS or tbS’ cleaved by thrombin in the absence or presence of PMSF. B. SDS-PAGE analysis of time course cleavage of the purified
fusion protein for eDAL at undesired cryptic sites by enterokinase. The fusion protein is indicated by the arrow. C. The purified fusion protein for
sDAL was cleaved into two parts by enterokinase. The fusion protein and cleaved products are indicated by the arrows. D. coupled assay of time
course cleavage of the purified fusion protein for sDAL by enterokinase. The activity of DAL partner was used as the control and subtracted.
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(Figure 4B). When eDAL was substituted with sDAL,
the fusion protein was only cleaved in two parts, His6-
GST and sDAL (Figure 4C). Consistently, proteolysis-DAL
coupled assay showed that, with prolonged time of entero-
kinase incubation, sDAL activity increased. Adding PMSF
inactivated the DAL activity presumably by inhibiting
the enterokinase-directed proteolysis (Figure 4D). The
selected DAL from the special organism is suitable for
analysis of the activity of enterokinase.Application of DAL-fusion substrate for intein
self-cleavage activity
We tested the possibility of using DAL-fusion protein as
substrate for the self-cleavage reaction. To increase the fu-
sion protein expression level, we constructed a chimeric
protein using His6-MBP, Ssp DnaB intein and eDAL. This
MBP-intein-eDAL had much improved expression of the
soluble protein in E. coli, and was purified with high purity
(Figure 5A). The fusion protein from the crude extract
and in the purified form was cleaved at pH 6.5, 4°C
and 30°C. The released DAL activity was measured at
pH 8.0 at 37°C for 5 min to access the self-cleavage effi-
ciency (Figure 5B and 5C). DAL activity increased dra-
matically between 0 and 12 h, dropped slightly between
12–24 h, which corresponded with the self-cleavage of
the purified fusion protein as shown by SDS-PAGE
analysis (Figure 5D). The result also indicates that the
intein-DAL coupled activity assay could measure theFigure 5 Self-cleavage efficiency of MBP-intein-eDAL at pH 6.5 and at
purified fusion protein. The specific bands were indicated by the arrow. B a
time from crude extract and in purified form were analyzed by coupled ass
detected by SDS-PAGE analysis.intein self-cleavage activity in cell lysate and does not
require purified protein.
Application of DAL-fusion substrate for SUMO protease
in vitro and in E. coli cells
We also tested the possibility of using DAL-fusion protein
as substrate for SUMO protease Ulp. Two yeast Ulp1 con-
structs were investigated. First, the constructed protease
and protein substrate were purified by Ni-NTA to homo-
geneity (Figure 6A). Different from previous observation
[5], the purified His6-tagged Ulp1 with a His6-tag became
completely precipitated and inactivated in buffer (50 mM
Tris/HCl, 100 mM NaCl, pH 8.0) after storing at −20°C
overnight, but the HisMBP-tagged Ulp1 was stable and
used for most of the analysis. Using the fusion protein
His6SUMO-eDAL as a substrate, we showed that Ulp1
activity was temperature dependent. Ulp1 activity was
increased from 30 to 35°C, but became decreased after
35°C, with the maximum activity at 35°C. For fresh pro-
tease, His6MBP tagged Ulp1 was more active than His6
tagged Ulp1 at 35°C, while the activities were almost
equal at temperature between 35–45°C (Figure 6B).
Finally, we would like to check whether Ulp1 activity
could be quantitatively measured in vivo using the fu-
sion protein substrate. We co-expressed His6- or His6MBP
tagged Ulp1 together with the protein substrate in E. coli.
The cleavage of the fusion protein was monitored by SDS-
PAGE and the DAL activity assay. Ulp1 could cleave the
protein substrate in E. coli cells, as shown by SDS-PAGE
and Western blot analysis (Figure 6C and 6D). Consistently,4°C and 30°C respectively. A. SDS-PAGE analysis of expressed and
nd C, self-cleavage activity of fusion protein at different incubation
ay. D: self-cleavage of fusion protein at corresponding incubation time
Figure 6 In vitro and in vivo cleavage of His6SUMO-eDAL by the Ulp1 constructs. A SDS-PAGE analysis of the purified fusion protein and
two Ulp1 constructs (His6MBP-Ulp1 and His6-Ulp1). The corresponding proteins are indicated by the arrows. B: in vitro cleavage of SUMO-eDAL
by two Ulp1 constructs at the different temperatures by coupled assay. C-E: in vivo cleavage of SUMO-eDAL by Ulp1 constructs detected by SDS-
PAGE and Western blot analysis, and activity measurement of the released DAL. Lane1: cells carrying the plasmids pSUMO-eDAL and pMAL-c2x.
Lane 2: cells containing pSUMO-eDAL and pMAL-c2x-Ulp1. Lane 3: cells harboring pSUMO-eDAL and pCDF-Duet1. Lane 4: cells carrying pSUMO-eDAL
and pCDF-Ulp1. The expressed His6SUMO-eDAL and cleaved His6SUMO were indicated by the arrows. The colume in Figure 6E represented the
corresponding DAL activities. The in vivo and in vitro activity of DAL as the fusion partner was applied as the control and subtracted.
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the control cells that harbored pSUMO-eDAL vector
and the control plasmid (the plasmid without insertion
of the gene encoding Ulp1). Furthermore, cells express-
ing His6MBP-Ulp1 showed higher DAL activity than
cells expressing His6-Ulp1 (Figure 6E). These observa-
tions support that the activity of Ulp1 could be measured
by cleaving the protein substrate through the activity of
liberated eDAL in E. coli.
Discussion
Fusion protein substrates are important tools for quanti-
tatively measuring the activity of proteases, and can be
used for protease engineering to improve specificity,
solubility and folding, and for quick protease activity
assay. Several fusion protein substrates have been devel-
oped before, but a more sensitive and inexpensive sub-
strate that can be used both in vitro and in cells is still
lacking. Here, based on the finding that N-terminal
tagged eDAL and sDAL had much lower DAL activity
(3.9 and 4.0 U/mg) than the untagged enzymes (80 ± 20
and 190 ± 20 U/mg) [22], we propose that the fused
DAL might be suitable as protease substrate and the
proteolysis-DAL coupled assay could be used to quanti-
tatively determine the protease activity. We show, unlike
some other protein substrate produced in E. coli, DALcan be fused with different tags. A select group of tags
provided sufficient yield and inhibition of eDAL and sDAL
activity. Moreover, we also optimized several fusion tags
that had further improved yield and activity of DAL pro-
teins to allow directly measuring the DAL activity even in
cell lysate. Without purification, sDAL-fusion proteins
provided higher sensitivity than that of eDAL-fusion in
this proteolysis-DAL coupled assay. Thus, our results
indicate that the recombinant DAL-fusion proteins can
be developed as a common protein substrate platform
for directly analyzing protease activity.
Fusion tags acted differently on the production and
stability of the target proteins with the incorporated cleav-
age sequence [25]. Several approaches can be applied to
overcome this problem. For example, in this study, we
found that inclusion of an rpS greatly decreased the
expression of fusion protein. Attempts to enhance the
expression level of His6GST-rpS-eDAL at various growth
temperatures and induction by IPTG at different con-
centration were failed. However, substitution of His6-GST
with His6-MBP considerably improved the expression
of the fusion protein (Figure 3A). The low expression
of His6GST-rpS-eDAL may not be caused by some uni-
versal feature of rpS. In fact, the pGEX vectors are com-
mercial available for expression of GST-fusion protein
containing rpS under control of a tac promoter. Our
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with the DAL and GST sequence. Fusion protein sub-
strates for different protease should be optimized spe-
cifically even when a universal protein platform is used,
such as DAL.
In addition to the gain of activity after proteolysis, DAL
shows other important features as ideal protease substrate.
First, DAL activity is insensitive to all tested protease spe-
cific inhibitors such as PMSF, BzCl and NEM. These in-
hibitors modify the serine and cysteine residues to inactive
proteases either covalently or noncovalently, while two
residues (Lys77 and Asp120) are potential catalytic resi-
dues as determined in the eDAL structure [26]. Second,
DAL activity also remains constant with the presence of
metal ions such as Ca2+ or metal ion chelators such as
EDTA, which are required for protease activity. Thus, the
orthologous reaction of DAL poses it as a great candidate
to monitor protease activity in various experimental
conditions.
DAL-fusion also provides a platform to identify speci-
ficity of the target protease. Serine proteases such as
thrombin, enterokinase and factor Xa are widely applied
for removing the fusion tag. Accumulated evidence indi-
cates that these proteases showed relatively low stringent
specificity and often cleave the fusion protein at loca-
tions other than the designed site and development of
next generation of serine proteases with higher substrate
is desired [4].Thrombin has a preference for serine at
P1’ position [4]. Consistently, our DAL-fusion substrates
showed that the specific activity of thrombin for cleaving
LTPRS is nearly one and half folds of that for LTPRG.
Further, enterokinase exhibits a preference for substrates
with motif D/ERM, as well as LKGDR, which are cleaved
more efficiently than the canonical DDDDK recognition
sequence [27,28]. In this study, we found that enterokinase
cleaved both eDAL and sDAL substrates but yielded no
DAL activity in eDAL. In-depth analysis showed that en-
terokinase also cleaved the eDAL at some cryptic sites.
The possible enterokinase cleavage sequence was deduced
in eDAL, and only VKGD amino acids similar to the re-
ported LKGDR are different from the alignment of sDAL
and eDAL sequences (See Additional file 2: Figure S2).
Based on our research, the designed DAL-fusion protein
substrate could be applied to analyze the known protease
specificity, but also be useful in detecting unidentified
substrate specificity of target proteases.
Application of DAL-fusion platform is not limited to
simple proteolysis. Self-cleaving tags in fusion proteins
possess inducible proteolytic activities. They enable fu-
sion purification, cleavage and target protein separation
to be achieved in a single step and are widely used in
protein production [6]. Induction of the intein-mediated
cleavage can be achieved by thiol reagents or pH and/or
temperature shift, depending on the particular constructused [6]. This has allowed many proteins (as N-terminal
fusion) to be overexpressed and purified using Ssp DnaB
intein as self-cleavage tag. A direct approach to monitor
the efficiency of self-cleavage has not been developed.
We showed the DAL-fusion platform could be applied
for this purpose. Further, we showed a His6-MBP tag
could dramatically increase expression level of the fusion
through direct examination of the intein activity by the
proteolysis-DAL coupled assay. This finding is of par-
ticular application for other target proteins (instead of
eDAL), which His6-MBP tag will allow it to be directly
purified by cleaving the chimeric protein on either Ni-NTA
or amylase resin. In contrast, while purification tags in-
cluding chitin binding domain, Phasin, phaR, ELP, His6
and cellulose-binding module had been used together with
Ssp DnaB intein, they do not often lead to soluble proteins
in E. coli [6].
SUMO-specific proteases represent a special class of
protease that recognizes a much larger substrate identity.
SUMO-specific proteases such as Ulp1 recognize the C-
terminal end of SUMO and hydrolyze peptide or isopep-
tide bonds to the carboxyl group of the C-terminal glycine
residue [5]. Here we show that DAL-fusion platform can
also be used as substrate to monitor SUMO protease
activity. The cleavage of SUMO-eDAL by two Ulp1 con-
structs showed different DAL activities, supporting the
difference of these two Ulp1 enzymes. Because of the
shared mechanism between SUMO and ubiquitin transfer-
ence, in the future, by exchanging SUMO with ubiquitin,
it might be possible to analyze the conformational-specific
de-ubiquitin enzymes using DAL-fusion platform [5].
Up to now, a few specific proteases have been produced
in E. coli, while further engineering of these protease are
needed to overcome their impaired folding and less solu-
bility. Several strategies have been exploited to improve
the intrinsic defects [4], for example, the change of some
amino acid residues on the surface of TEVp and human
enterokinase by site-directed mutagenesis [29,30], which
all require to quantitative measure the protease activity.
Our developed DAL-fusion protease substrate will provide




Amylase resin, the plasmids pMAL-c2x and pTWIN1 are
products of NEB, USA. Ni-NTA and proteases including
factor Xa, enterokinase and thrombin are bought from
Novagen, USA. E. coli strain BL21(DE3), and pET28b and
pCDF-Duet1 vectors, and reagents for Western blot ana-
lysis are supplied by Novagen, USA. Ni-NTA superflow
was obtained from Qiagen (Chatsworth, CA). Ultra-15
centrifugal filter tube equipped with Ultracel-10 mem-
brane was supplied by Amicon (USA). The compounds
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DL-DAP, PMSF, NEM, BzCl were from Sigma. Primer syn-
thesis and DNA sequencing were performed by Invitrogen
(Shanghai, China). Reagents used in plasmid construction
and protein expression were from Takara (Dalian, China).
The purified GST fused R3P is generously provided by
Professor Zang Jianye, University of Science and Tech-
nology of China. The TEVp variant with five amino acid
mutations are purified previously [23].
Plasmids construction
The plasmid pGST-eDAL for expression of eDAL with a
His6GST followed by a TEVp cleavage sequence was con-
structed [23]. The gene encoding sDAL was amplified by
PCR using S. typhimurium genomic DNA as the template
and substituted the sequence encoding eDAL to yield
pGST-sDAL. Further, His6GST was replaced with either
His6MBP or His6-tag. By overlap PCR, the recognition se-
quence for TEVp was exchanged by that for other prote-
ase including ekS, fxS, rpS, tbS and tbS’. The plasmid
pMID encoding the MBP-intein-eDAL fusion protein was
constructed. The gene fragment encoding Ssp DnaB in-
tein was amplified by PCR using pTWIN1 vector as the
template, and inserted into pMAL-c2x. Then, the gene
encoding eDAL was subcloned into downstream of cod-
ing sequence of Ssp DnaB intein. The eDAL gene was
also amplified, digested with the specified restrictive
endonuclease, and inserted into pTYB21 vector. The
sumt3 and Ulp1 were amplified using Saccharomyces
cerevisiae genomic DNA as the template, based on the
published literature [2]. The amplicon was cut and inserted
into pET28b, to generate the plasmids p28SUMO and
p28Ulp1 respectively. The gene encoding eDAL was cut
from pGST-eDAL and inserted into p28SUMO to create
the plasmid pSUMO-eDAL. The Ulp1 in the plasmid
p28Ulp1 was excised and subcloned into pCDF Duet I
to yield pCDF-Ulp1. This gene was also amplified and
inserted into pMAL-c2x, to generate the plasmid pMAL-
Ulp1 for expressing MBP-Ulp1 fusion protein. The
primers were listed in Additional file 3: Table S1. All
the amplified gene fragments were sequenced.
Overexpression and purification of the fusion proteins
The constructed plasmid was transformed into BL21
(DE3). The transformants were cultured overnight at 37°C
and diluted 1:200 in LB culture. When OD600 were up to
0.5 at 37°C, IPTG at final concentration of 0.5 mM was
added and the cells were grown overnight at 28°C. Cells
were collected by centrifugation and dissolved in buffer A
buffer A (20 mM Tris/HCl, 100 mM NaCl, pH 8.0), and
disrupted by sonication at 4°C. After centrifugation, the
supernatant was collected. Protein concentration was
determined by coomassie brilliant blue R250, using bo-
vine serum albumin as standard. Soluble fractions wereseparated on 15% SDS-PAGE gel and electro blotted
onto PVDF membrane. The membrane was blocked
with PBST (10 mM phosphate buffer with 150 mM
NaCl, 0.05% Tween 20 and 5% skimmed milk) for
40 min at room temperature, and then incubated for 2 h
with anti-His6 or SUMO mouse monoclonal antibody
diluted in PBST with 5% skimmed milk. After three
washes with PBST buffer, the membrane was incubated
for 1 h with horseradish peroxidase conjugated anti-
mouse IgG diluted in PBST with 5% skimmed milk,
washed three times and specific proteins were visualized
by adding 4-chloro-1-naphthol solution dissolved in
20% methanol and 0.08% hydrogen peroxide in PBST.
The cells overexpressing the fusion protein were also
disrupted in buffer B (50 mM sodium phosphate, 300 mM
NaCl and 10 mM imidazole, pH 8.0). The supernatants
were loaded on a 3-ml Ni-NTA resin packed in a 15 ml
column, pre-equilibrated with three column volumes of
buffer B, then washed and eluted with three column
volumes of 30 and 250 mM imidazole in buffer B. The
MBP-Ulp1 was purified by amylase resin according to
NEB protocol. All the purified fusion proteins were
concentrated, exchanged with buffer A, and analyzed
by 15% SDS-PAGE.
In vitro and in vivo cleavage of the designed fusion
protein
The Ulp1, TEVp, or rhinovirus 3C protease in buffer A,
thrombin in buffer C (20 mM Tris–HCl, 100 mM NaCl,
and 1 mM CaCl2, pH 7.5), factor Xa or enteropeptidase
in buffer D (20 mM Tris–HCl, 100 mM NaCl, and
1 mM CaCl2, pH 8.0), cleaved the corresponding fusion
protein at 25°C. About 0.5 ml of crude extracts of E .coli
cells overexpressing the fusion protein were mixed with
the different concentration of protease solutions. At the
indicated time points, aliquots were withdrawn and the
activity released DAL was analyzed. The activity of the fu-
sion protein for DAL was assayed and subtracted. The
corresponding samples were boiled for 5 min and analyzed
by SDS-PAGE.
E. coli BL21 (DE3) overexpressing SUMO-eDAL and
Ulp1 with a N-terminal His6-tag or MBP were cultured
overnight at 37°C in the presence of the corresponding
antibiotics. Cells harboring the plasmids pSUMO-eDAL
and pCDF-Ulp1 or pMAL-Ulp1 (The plasmid pCDF-
Duet1 or pMAL-c2x as control) were collected, disrupted
in buffer A, and centrifuged. The supernatants were ana-
lyzed by SDS-PAGE. The DAL activity was assayed.
DAL activity analysis
DAL activity was measured in the absence or presence
of each of the reagents including 2.5 mM Ca2+, 5 mM
EDTA-Na2, 1 mM NEM, 1 mM PMSF and 1 mM BzCl.
DAL catalyzes DL-DAP to generate pyruvate and ammonia.
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reaction mixture in 1 ml contained 50 μM PLP and 10 mM
DL-DAP and the protein. The assay was started at 37°C for
5 min and stopped by adding 1 ml of 2 mM HCl containing
0.03% 2,4-DNP. The mixture was incubated at 4°C for
5 min, and 2 ml of 2 M NaOH was added. Absorbance at
520 nm was recorded on a U-2001 spectrometer (Hitachi,
Japan). The experiments were carried out in triplicates.
One unit of enzyme activity was defined as the amount
of enzyme required to catalyze the release of 1 μmol of
pyruvate/min at 37°C, pH 8.0.
Additional files
Additional file 1: Figure S1. The expression level of Sce-VMA1-CBD-
intein-eDAL by SDS-PAGE analysis. The fusion protein was overexpressed
in E. coli BL21(DE3) under induction with 0.5 mM IPTG for 12 h at 28°C,
and indicated by the arrow.
Additional file 2: Figure S2. Amino acid sequence alignment of eDAL
and sDAL. The deduced cleavage site for enterokinase in the loop of eDAL
was labeled in red color. Figure was prepared with programme CLUSTAL W.
Additional file 3: Table S1. The primers used in this study.
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